- Shire (NASDAQ:SHPG) has filed its first submission to the FDA for the company's new plasma manufacturing facility in Covington, Georgia.
- The location is expected to add approximately 30% capacity to the company's internal network once fully operational.
- Commercial production is expected to begin in 2018.